Skip to content
The Longevity Archive
BGE-102 in all countries

Legal status · Canada

Is BGE-102 legal in Canada?

InvestigationalLongevityEvidence: Preliminary

No. BGE-102 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.

BGE-102 in Canada at a glance

ClassificationInvestigational, not approved
Health Canada approval statusNot approved by Health Canada; investigational
Evidence levelPreliminary (research strength: Preliminary)
ReviewedSep 2026

Classification and note come from the BGE-102 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.

What this means

  • 01

    BGE-102 is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What BGE-102 is

BioAge's brain-penetrant NLRP3 inhibitor that cut the inflammation marker hsCRP by a median 86% in two weeks in Phase 1, the strongest human anti-inflammaging signal from a geroscience company so far.

NLRP3 is the inflammasome that drives IL-1beta and much of the chronic low-grade inflammation of aging. In a Phase 1 reported in April 2026, 120 mg of BGE-102 daily lowered hsCRP by a median 86% by day 14 in adults with obesity and elevated inflammation, with only mild to moderate adverse events.

Mechanism: Small-molecule inhibition of the NLRP3 inflammasome, blocking caspase-1 activation and IL-1beta release.

Regulatory history: Investigational; Phase 1/2

How Health Canada treats this kind of product

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for BGE-102 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

BGE-102 in other countries

Frequently asked questions

Is BGE-102 legal in Canada?

No. BGE-102 is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.

Can I buy BGE-102 in Canada?

No approved product exists to buy. In Canada BGE-102 is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is BGE-102 Health Canada approved?

No. In Canada BGE-102 is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational; Phase 1/2. Evidence level: Preliminary.

Related compounds in Canada

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for BGE-102 live on its compound profile.

BGE-102 profile

This page is general information about the regulatory status of BGE-102 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.